The effort aims to educate physicians, caregivers and patients on how genomic testing of solid tumors during the early stages of a patient’s care plan can help to inform personalized treatments.
The educational initiative will take a case-based approach — based on CTCA’s use of Foundation Medicine’s comprehensive genomic profile platform — describing several cancer patients’ journeys from diagnosis to tumor profiling to treatment.
“As oncologists, we have an obligation to the patients we serve to keep pace with, and, whenever possible, lead the way in the application of the latest diagnostic tools that may help inform treatment decisions,” said Maurie Markman, MD, president of medicine and science at CTCA.
More articles on population health:
How video games could help treat mental disorders
California: Pathologists must report cancer diagnoses to electronic registry by 2019
Virginia Tech researchers examine environmental health disparities in Appalachia
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
